论文部分内容阅读
据美国胃肠病学会(AGA)主办的《胃肠学》杂志近期发表的一项研究估计,美国患有巴雷特食管病的患者约为300余万;此病症可诱发食道癌,是目前美国增长速度最快的癌症疾患之一。这些首次基于人群对巴雷特食管病流行情况评估的研究发现表明,无胃食管返流疾病患者的该病发生率较为常见,同时临床亦将其视为是巴雷特食管病的前期征兆。美国南亚利桑那州弗吉尼亚健康保健中心的Richard E.Sampliner对此评价说,研究结果有助于了解普通成年人群中巴雷特食管病流行病学研究所取得的重要进展;而下一步的研究重点则是在无返流疾患人群中进行巴雷特食管病的筛查,以准确地鉴别高风险的或存活的该病患者。
According to a recent study published by the Gastroenterology Society sponsored by the American Gastroenterological Association (AGA), there are estimated to be about 3 million patients with Barrett’s esophagus in the United States. This condition can induce esophageal cancer and is currently One of the fastest growing cancer diseases in the United States. These first-time population-based studies evaluating Barrett’s esophageal prevalence suggest that the incidence of this disease is more common in patients without gastroesophageal reflux disease and clinically as an early sign of Barrett’s esophageal disease. Richard E.Sampliner of the Virginia Health Care Center in South Arizona, USA, commented that the findings help to understand the important advances made in Barrett’s epidemiology of Barrett’s disease in the general adult population. However, the next research focus Screening for Barrett’s esophageal disease in people with no reflux disease to accurately identify patients at high risk or surviving the disease.